Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+2.16%)
As of: Oct 21, 2026 · 10:01 AM EDT

Oncotelic Therapeutics (OTLC) Operating Margin (2012 - 2026)

Updated

Oncotelic Therapeutics (OTLC) recorded Operating Margin of -337.43% in Q2 2026.

Analysis

Oncotelic Therapeutics (OTLC) Operating Margin (2012 - 2026) Analysis & Trends

On a TTM basis, Oncotelic Therapeutics' Operating Margin came in at -1227.83% as of Jun 30, 2026; for FY2023, it came in at -9497.16%.

  • Annual Operating Margin has a three-year change of -9061.47 percentage points (FY2020 to FY2023).
  • Across earlier years, Operating Margin came in at -1825.18% in FY2021 (-1389.49 pp) and -435.69% in FY2020.
  • The Q2 2026 figure is the highest quarterly Operating Margin since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,133.02 Bn 1,101.60 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 616.49 Bn 535.01 Bn 17.26 Bn 28.21%
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 37.86%
4 Merck 366.78 Bn 321.16 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.96 Bn 261.95 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 20.57%
7 Amgen 235.44 Bn 190.84 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.69 Bn 164.89 Bn 6.22 Bn -133.21%
9 Pfizer 169.52 Bn 116.16 Bn 10.94 Bn 28.37%
10 Oncotelic Therapeutics 8.46 Mn 7.60 Mn - -337.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -337.43%
Sep 30, 2023 20.68%
Mar 31, 2021 -407.58%
Jun 30, 2020 0.99%
Mar 31, 2020 -777.06%
Sep 30, 2013 -2,786.32%
Dec 31, 2012 -3,978.57%
Mar 31, 2012 -1,653.51%
API Access

Oncotelic Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=OTLC&period=max&api_key=YOUR_API_KEY